Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Blockade of interleukin 6 signaling induces marked neutropenia in patients with rheumatoid arthritis.

× No keyword cloud information.

10 in total

Review 1. Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature.

Authors: O Shovman; Y Shoenfeld; P Langevitz
Journal: Immunol Res Date: 2015-02 Impact factor: 2.829

2. Disentangling the effects of tocilizumab on neutrophil survival and function.

Authors: Timo Gaber; Martin Hahne; Cindy Strehl; Paula Hoff; Yvonne Dörffel; Eugen Feist; Gerd-Rüdiger Burmester; Frank Buttgereit
Journal: Immunol Res Date: 2016-06 Impact factor: 2.829

Review 3. Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence.

Authors: Sambhawana Bhandari; Maun Ranjan Baral; Matthew Barbery; Alla Rudinskaya; Oleg Sostin
Journal: Ann Hematol Date: 2022-06-27 Impact factor: 4.030

4. Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).

Authors: Hisashi Yamanaka; Yoshiya Tanaka; Eisuke Inoue; Daisuke Hoshi; Shigeki Momohara; Kentaro Hanami; Naoki Yunoue; Kazuyoshi Saito; Kouichi Amano; Hideto Kameda; Tsutomu Takeuchi
Journal: Mod Rheumatol Date: 2010-10-16 Impact factor: 3.023

Review 5. Neutrophil Homeostasis and Emergency Granulopoiesis: The Example of Systemic Juvenile Idiopathic Arthritis.

Authors: Bert Malengier-Devlies; Mieke Metzemaekers; Carine Wouters; Paul Proost; Patrick Matthys
Journal: Front Immunol Date: 2021-12-13 Impact factor: 7.561

Review 6. Immune-related adverse events of biological immunotherapies used in COVID-19.

Authors: Daniela Baracaldo-Santamaría; Giovanna María Barros-Arias; Felipe Hernández-Guerrero; Alejandra De-La-Torre; Carlos-Alberto Calderon-Ospina
Journal: Front Pharmacol Date: 2022-08-25 Impact factor: 5.988

7. Biological targets in the treatment of rheumatoid arthritis: a comprehensive review of current and in-development biological disease modifying anti-rheumatic drugs.

Authors: Manil Kukar; Olga Petryna; Petros Efthimiou
Journal: Biologics Date: 2009-10-12

8. Selective Interleukin-6 Trans-Signaling Blockade Is More Effective Than Panantagonism in Reperfused Myocardial Infarction.

Authors: Marc Jonathan George; Nur Hayati Jasmin; Valerie Taylor Cummings; Angela Richard-Loendt; Francesca Launchbury; Kevin Woollard; Tabitha Turner-Stokes; Ana Isabel Garcia Diaz; Mark Lythgoe; Daniel James Stuckey; Aroon Dinesh Hingorani; Derek William Gilroy
Journal: JACC Basic Transl Sci Date: 2021-04-07

Review 9. Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis.

Authors: C Giraud; Z Tatar; M Soubrier
Journal: Clin Rheumatol Date: 2016-08-19 Impact factor: 2.980

10. Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.

Authors: Marc J George; Ola Kleveland; Jorge Garcia-Hernandez; Jutta Palmen; Ruth Lovering; Rune Wiseth; Pål Aukrust; Jorgen Engmann; Jan Kristian Damås; Aroon D Hingorani; Lars Gullestad; Juan P Casas; Thor Ueland
Journal: J Am Heart Assoc Date: 2020-06-09 Impact factor: 5.501

10 in total